AAAAAA
Results:
1-14
|
Results: 14
Authors:
Okayama, A
Stuver, S
Iga, M
Okamoto, M
Mueller, N
Matsuoka, M
Yamaguchi, K
Tachibana, N
Tsubouchi, H
Citation: A. Okayama et al., Sequential change of virus markers in seroconverters with community-acquired infection of human T lymphotropic virus type I, J INFEC DIS, 183(7), 2001, pp. 1031-1037
Authors:
Hoffmann, P
Mueller, N
Shively, JE
Fleischer, B
Neumaier, M
Citation: P. Hoffmann et al., Fusion proteins of B7.1 and a carcinoembryonic antigen (CEA)-specific antibody fragment opsonize CEA-expressing tumor cells and coactivate T-cell immunity, INT J CANC, 92(5), 2001, pp. 725-732
Authors:
Abtahi, A
Mueller, N
Okayama, A
Stuver, S
Citation: A. Abtahi et al., Lack of evidence for a role of HTLV-I infection in the occurrence of subclinical HAM/TSP in the Miyazaki Cohort Study, J ACQ IMM D, 24(1), 2000, pp. 86-87
Authors:
Ehsani, ME
Abraha, TW
Netherland-Snell, C
Mueller, N
Taylor, MM
Holwerda, B
Citation: Me. Ehsani et al., Generation of mutant murine cytomegalovirus strains from overlapping cosmid and plasmid clones, J VIROLOGY, 74(19), 2000, pp. 8972-8979
Authors:
Stuver, SO
Boschi-Pinto, C
Okayama, A
Mueller, N
Citation: So. Stuver et al., Possible mechanism for positive interaction of human T cell leukemia type I on liver disease in a hepatitis C virus-infected Japanese cohort - Reply, J INFEC DIS, 182(1), 2000, pp. 379-380
Authors:
Boschi-Pinto, C
Stuver, S
Okayama, A
Trichopoulos, D
Orav, EJ
Tsubouchi, H
Mueller, N
Citation: C. Boschi-pinto et al., A follow-up study of morbidity and mortality associated with hepatitis C virus infection and its interaction with human T lymphotropic virus type I in Miyazaki, Japan, J INFEC DIS, 181(1), 2000, pp. 35-41
Authors:
Stuver, SO
Tanaka, K
Ikematsu, H
Okayama, A
Tachibana, N
Hirohata, T
Kashiwagi, S
Tsubouchi, H
Mueller, N
Citation: So. Stuver et al., Re: "Heterosexual transmission of hepatitis C virus among married couples in southwestern Japan", INT J CANC, 88(5), 2000, pp. 833-834
Authors:
Mueller, N
Citation: N. Mueller, Infectious agents, CANC PR CAN, 1, 2000, pp. 63-73
Authors:
Mueller, N
Citation: N. Mueller, Overview of the epidemiology of malignancy in immune deficiency, J ACQ IMM D, 21, 1999, pp. S5-S10
Authors:
Suzuki, M
Dezzutti, CS
Okayama, A
Tachibana, N
Tsubouchi, H
Mueller, N
Lal, RB
Citation: M. Suzuki et al., Modulation of T-cell responses to a recall antigen in human T-cell leukemia virus type 1-infected individuals, CL DIAG LAB, 6(5), 1999, pp. 713-717
Authors:
Li, X
Schaepkens, M
Oehrlein, GS
Ellefson, RE
Frees, LC
Mueller, N
Korner, N
Citation: X. Li et al., Mass spectrometric measurements on inductively coupled fluorocarbon plasmas: Positive ions, radicals and endpoint detection, J VAC SCI A, 17(5), 1999, pp. 2438-2446
Authors:
Touloumi, G
Hatzakis, A
Potouridov, I
Milona, I
Strarigos, J
Katsambas, A
Giraldo, G
Beth-Giraldo, E
Biggar, RJ
Mueller, N
Trichopoulos, D
Citation: G. Touloumi et al., The role of immunosuppression and immune-activation in classic Kaposi's sarcoma, INT J CANC, 82(6), 1999, pp. 817-821
Authors:
Etoh, K
Yamaguchi, K
Tokudome, S
Watanabe, T
Okayama, A
Stuver, S
Mueller, N
Takatsuki, K
Matsuoka, M
Citation: K. Etoh et al., Rapid quantification of HTLV-I provirus load: Detection of monoclonal proliferation of HTLV-I-infected cells among blood donors, INT J CANC, 81(6), 1999, pp. 859-864
Authors:
Sleckman, BG
Mauch, PM
Ambinder, RF
Mann, R
Pinkus, GS
Kadin, ME
Sherburne, B
Perez-Atayde, A
Thior, I
Mueller, N
Citation: Bg. Sleckman et al., Epstein-Barr virus in Hodgkin's disease: Correlation of risk factors and disease characteristics with molecular evidence of viral infection, CANC EPID B, 7(12), 1998, pp. 1117-1121
Risultati:
1-14
|